March

March 15, 2017

Molecular therapy for Myocardial Infarction: ZBTB2 (Zinc Finger And BTB Domain Containing 2) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 15/March/2017, 1.00 pm

What they say:   A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof […]
March 14, 2017

Natural product therapy for Glaucoma: Berberine, isolated from Berberis aristata, Oregon grape, Hydrastis canadensis (goldenseal), Xanthorhiza simplicissima (yellowroot), and Phellodendron amurense (Amur cork tree) among others, increases Nmnat1 expression, increases NAD+ levels, improves neuroanl dysfunction, and protects against glaucoma via down regulation of its target gene, 14/March/2017, 11.16 pm

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]
March 14, 2017

Natural product-based therapy for TIIDM and obesity-associated metabolic deficits: Ursolic acid, isolated from Mirabilis Jalapa, Ocimum sanctum, and Apple peels among others, increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM via down regulation of its target gene, 14/March/2017, 1.07 pm

Introduction: What they say A study from the Department of Physiology-Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA shows that […]
March 14, 2017

Amino acid-based therapy for pulmonary fibrosis: L-Leucine decreases miR-34 expression, increases Sirtuin-1 expression, suppresses tumor suppressor p53 acetylation, prevents apoptosis in Alveolar epithelial cell (AEC), and improves pulmonary fibrosis via down regulation of its target gene, 14/March/2017, 11.34 am

What we say:  Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Amino acid-based therapy for pulmonary fibrosis: L-Leucine decreases miR-34 expression, increases Sirtuin-1 expression, suppresses tumor suppressor p53 […]